Health care industry
Delayed Release of New Anti-Impotence Drug in South Korea
The release of a new anti-impotence drug, Zydena, by South Korea's largest drug company, Dong-A Pharmaceutical, is likely to be delayed due to concerns over cancer-causing substances. The Korea Food and Drug Administration (KFDA) has ordered the company to provide additional information on its submitted files for screening.